Phase I/II Clinical Trial of Hyaluronan-Cisplatin Nanoconjugate for the Treatment of Spontaneous Canine Cancers

OBJECTIVE: To conduct an open label, multi-dose Phase I/II clinical study in spontaneous canine cancers and evaluate the pharmacokinetics, safety, and efficacy of the hyaluronan-based cisplatin formulation (HA-Pt). ANIMALS: 13 dogs with heterogeneous, naturally occurring cancers. PROCEDURES: The dog...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Vet Res
Main Authors: Cai, Shuang, Zhang, Ti, Forrest, W.C., Yang, Qiuhong, Groer, Chad, Mohr, Eva, Aires, Daniel J., Axiak-Bechtel, Sandra M., Flesner, Brian K., Henry, Carolyn J., Selting, Kimberly A., Tate, Deborah, Swarz, Jeffrey A., Bryan, Jeffrey N., Forrest, M. Laird
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5008241/
https://ncbi.nlm.nih.gov/pubmed/27580113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2460/ajvr.77.9.1005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados